Volume 56, Issue 3, Pages (March 2012)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 50, Issue 4, Pages (April 2009)
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 59, Issue 1, Pages (July 2013)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 58, Issue 1, Pages (January 2013)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 42, Issue 1, Pages (January 2005)
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 57, Issue 6, Pages (December 2012)
Volume 69, Issue 2, Pages (August 2018)
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy  M. Pollicita, C. Alteri, M.C.
Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention  Stanley M. Lemon, Jördis J. Ott, Pierre.
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
A. Zeytinoğlu, S. Erensoy, H. Abacioğlu, A. A. Sayiner, T. Özacar, A
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
L. Dubourg  Clinical Microbiology and Infection 
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 68, Issue 4, Pages (April 2018)
Autophagy in the liver Journal of Hepatology
Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative.
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing  F. Li, D. Zhang, Y. Li, D. Jiang, S. Luo, N. Du,
EASL Clinical Practice Guidelines: Wilson’s disease
Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection  P. Colson, C. Dhiver, R. Gérolami 
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Volume 50, Issue 2, Pages (February 2009)
Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences  C.M. Olinger, N.V.
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Volume 67, Issue 5, Pages (November 2017)
Volume 50, Issue 4, Pages (April 2009)
Emergence of Crimean–Congo haemorrhagic fever in Greece
Volume 56, Issue 6, Pages (June 2012)
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Immigration and viral hepatitis
Immunological techniques in viral hepatitis
Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains  P. Trémeaux, A. Caporossi,
Innate immunity and HCV
Volume 63, Issue 1, Pages (July 2015)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Molecular epidemiology and genetic diversity of human astrovirus in South Korea from 2002 to 2007  A.Y. Jeong, H.S. Jeong, M.Y. Jo, S.Y. Jung, M.S. Lee,
Volume 51, Issue 2, Pages (August 2009)
Detection of a new subgenotype of hepatitis B virus genotype A in Cameroon but not in neighbouring Nigeria  J.M. Hübschen, P.O. Mbah, J.C. Forbi, J.A.
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Sandfly fever virus outbreak in Cyprus
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Genetics of hepatocellular carcinoma: The next generation
Volume 70, Issue 5, Pages (May 2019)
Volume 53, Issue 4, Pages (October 2010)
Presentation transcript:

Volume 56, Issue 3, Pages 734-737 (March 2012) Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion- infected newborn to her mother  Christoph Niederhauser, Daniel Candotti, Tina Weingand, Andreas Maier, Caroline Tinguely, Martin Stolz, Jean-Pierre Allain  Journal of Hepatology  Volume 56, Issue 3, Pages 734-737 (March 2012) DOI: 10.1016/j.jhep.2011.07.034 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 1 General summary of the case. Dates on top of each box indicate the time of sample collection. The flow chart goes logically from infected blood donation to recipients to mother of Recipients 1 and Recipient 2, although the flow of HBV infection discovery went in the reverse order. n.d., test not done; ± indicates weak signal in the grey zone of the assay; ALT, alanine amino transferase is expressed in IU/l. HBV DNA level is expressed in IU/ml and anti-HBs level is expressed in IU/L. Journal of Hepatology 2012 56, 734-737DOI: (10.1016/j.jhep.2011.07.034) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Phylogenetic tree of the HBV full genome of three related infections. The Pre-S/S region sequenced includes 1190 nucleotides. 10,501, 10,255, and 10,499 correspond to the sequences of Recipient 1, her mother and Recipient 2, respectively. GenBank accession number followed by the hyphenated genotype identifies the reference sequences. The numbers on top of bars indicate the bootstrap value. Journal of Hepatology 2012 56, 734-737DOI: (10.1016/j.jhep.2011.07.034) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions